{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:59:50Z","timestamp":1763765990148},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,6,10]],"date-time":"2013-06-10T00:00:00Z","timestamp":1370822400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s00784-013-1012-5","type":"journal-article","created":{"date-parts":[[2013,6,9]],"date-time":"2013-06-09T02:10:44Z","timestamp":1370743844000},"page":"401-407","source":"Crossref","is-referenced-by-count":32,"title":["Prevalence of bisphosphonate-associated osteonecrosis of the jaw after intravenous zoledronate infusions in patients with early breast cancer"],"prefix":"10.1007","volume":"18","author":[{"given":"Petra","family":"Rugani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gero","family":"Luschin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Jakse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Kirnbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Acham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,10]]},"reference":[{"issue":"5 Suppl","key":"1012_CR1","first-page":"2","volume":"67","author":"SL Ruggiero","year":"2009","unstructured":"Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B, American Association of Oral and Maxillofacial Surgeons (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20142009 update. J Oral Maxillofac Surg 67(5 Suppl):2\u201312","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"1012_CR2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00784-009-0365-2","volume":"15","author":"T Ziebart","year":"2011","unstructured":"Ziebart T, Pabst A, Klein MO, Kammerer P, Gauss L, Brullmann D, Al-Nawas B, Walter C (2011) Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro. Clin Oral Investig 15(1):105\u2013111","journal-title":"Clin Oral Investig"},{"issue":"3","key":"1012_CR3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00784-009-0300-6","volume":"14","author":"S Hoefert","year":"2010","unstructured":"Hoefert S, Schmitz I, Tannapfel A, Eufinger H (2010) Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings. Clin Oral Investig 14(3):271\u2013284","journal-title":"Clin Oral Investig"},{"issue":"1","key":"1012_CR4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00784-009-0294-0","volume":"14","author":"J Rustemeyer","year":"2010","unstructured":"Rustemeyer J, Bremerich A (2010) Bisphosphonate-associated osteonecrosis of the jaw: what do we currently know? A survey of knowledge given in the recent literature. Clin Oral Investig 14(1):59\u201364","journal-title":"Clin Oral Investig"},{"issue":"5 Suppl","key":"1012_CR5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.joms.2009.01.007","volume":"67","author":"MR Allen","year":"2009","unstructured":"Allen MR, Burr DB (2009) The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data. J Oral Maxillofac Surg 67(5 Suppl):61\u201370","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"1012_CR6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","volume":"65","author":"Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons","year":"2007","unstructured":"Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons (2007) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65(3):369\u2013376","journal-title":"J Oral Maxillofac Surg."},{"key":"1012_CR7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","volume":"353","author":"BG Durie","year":"2005","unstructured":"Durie BG, Katz M, Crowley J (2005) Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 353:99\u2013102","journal-title":"N Engl J Med"},{"key":"1012_CR8","unstructured":"D\u00d6SAK (2011)StrkuturierteDatenerfassung der Bisphosphonat-assoziiertenKiefernekrosen (BP-ONJ). https:\/\/bp-onj-datenbank.de\/downloads\/E-081125_Fragebogen-OJN-DOESAK.pdf Accessed:29 January 2012"},{"issue":"4","key":"1012_CR9","first-page":"1233","volume":"52","author":"HA Alm\u0103\u015fan","year":"2011","unstructured":"Alm\u0103\u015fan HA, B\u0103ciu\u0163 M, Rotaru H, Bran S, Alm\u0103\u015fan OC, B\u0103ciu\u0163 G (2011) Osteonecrosis of the jaws associated with the use of bisphosphonates. Discussion over 52 cases. Rom J Morphol Embryol 52(4):1233\u20131241","journal-title":"Rom J Morphol Embryol"},{"issue":"4","key":"1012_CR10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/030089161109700411","volume":"97","author":"A Bantis","year":"2011","unstructured":"Bantis A, Zissimopoulos A, Sountoulides P, Kalaitzis C, Giannakopoulos S, Deftereos S, Tsakaldimis G, Thomaidis V, Touloupidis S (2011) Bisphosphonate-induced osteonecrosis of the jaw in patients with bone metastatic, hormone-sensitive prostate cancer. Risk factors and prevention strategies. Tumori 97(4):479\u2013483","journal-title":"Tumori"},{"key":"1012_CR11","first-page":"b147","volume":"77","author":"R Bonacina","year":"2011","unstructured":"Bonacina R, Mariani U, Villa F, Villa A (2011) Preventive strategies and clinical implications for bisphosphonate-related osteonecrosis of the jaw: a review of 282 patients. J Can Dent Assoc 77:b147","journal-title":"J Can Dent Assoc"},{"issue":"4","key":"1012_CR12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.oraloncology.2011.11.004","volume":"48","author":"M Schubert","year":"2011","unstructured":"Schubert M, Klatte I, Linek W, M\u00fcller B, D\u00f6ring K, Eckelt U, Hemprich A, Berger U, Hendricks J (2011) The Saxon Bisphosphonate Register\u2014therapy and prevention of bisphosphonate-related osteonecrosis of the jaws. Oral Oncol 48(4):349\u2013354. doi: 10.1016\/j.oraloncology.2011.11.004","journal-title":"Oral Oncol."},{"key":"1012_CR13","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1359\/jbmr.080205","volume":"23","author":"AO Hoff","year":"2008","unstructured":"Hoff AO, Toth BB, Altundag K, Johnson MM, Warneke CL, Hu M, Nooka A, Sayegh G, Guarneri V, Desrouleaux K, Cui J, Adamus A, Gagel RF, Hortobagyi GN (2008) Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res 23:826\u2013836","journal-title":"J Bone Miner Res"},{"key":"1012_CR14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","volume":"65","author":"T Mavrokokki","year":"2007","unstructured":"Mavrokokki T, Cheng A, Stein B, Goss A (2007) Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 65:415\u2013423","journal-title":"J Oral Maxillofac Surg"},{"key":"1012_CR15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1746-160X-6-11","volume":"6","author":"C Walter","year":"2010","unstructured":"Walter C, Al-Nawas B, Frickhofen N, Gamm H, Beck J, Reinsch L, Blum C, Gr\u00f6tz KA, Wagner W (2010) Prevalence of bisphosphonate associate osteonecrosis of the jaws in multiple myeloma patients. Head Face Med 6:11","journal-title":"Head Face Med"},{"key":"1012_CR16","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJMoa0806285","volume":"360","author":"M Gnant","year":"2008","unstructured":"Gnant M, Mlineritsch B, Stoeger H, Luschin-Ebengreuth G, Heck D, Menzel C, Jakesz R, Seifert M, Hubalek M, Bjelic-Radisic V, Samonigg H, Tausch C, Eidtmann H, Steger G, Kwasny W, Dubsky P, Fridrik M, Fitzal F, Stierer M, R\u00fccklinger E, Greil R, ABCSG-12 Trial Investigators, Marth C (2008) Endocrine therapy plus zoledronic acid in premenopausal breast cancer. N Engl J Med 360:679\u2013691","journal-title":"N Engl J Med"},{"key":"1012_CR17","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1634\/theoncologist.2007-0159","volume":"13","author":"T Ibrahim","year":"2008","unstructured":"Ibrahim T, Barbanti F, Giorgio-Marrano G, Mercatali L, Ronconi S, Vicini C, Amadori D (2008) Osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: a retrospective study. Oncologist 13:330\u2013336","journal-title":"Oncologist"},{"key":"1012_CR18","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","volume":"23","author":"A Bamias","year":"2005","unstructured":"Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnostopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA (2005) Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J ClinOncol 23:8580\u20138587","journal-title":"J ClinOncol"},{"key":"1012_CR19","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.joms.2007.03.006","volume":"65","author":"EP Wang","year":"2007","unstructured":"Wang EP, Kaban LB, Strewler GJ, Raje N, Troulis MJ (2007) Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy. J Oral Maxillofac Surg 65:1328\u20131331","journal-title":"J Oral Maxillofac Surg"},{"key":"1012_CR20","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ygyno.2008.11.029","volume":"112","author":"T Fehm","year":"2009","unstructured":"Fehm T, Beck V, Banys M, Lipp HP, Hairass M, Reinert S, Solomayer EF, Wallwiener D, Krimmel M (2009) Bisphosphonate-induced osteonecrosis of the jaw (ONJ): incidence and risk factors in patients with breast cancer and gynecological malignancies. Gynecol Oncol 112:605\u2013609","journal-title":"Gynecol Oncol"},{"key":"1012_CR21","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1634\/theoncologist.10-10-842","volume":"10","author":"V Guarneri","year":"2005","unstructured":"Guarneri V, Donati S, Nicolini M, Giovannelli S, D'Amico R, Conte PF (2005) Renal safety and efficacy of i.v. bisphosphonates in patients with skeletal metastases treated for up to 10 Years. Oncologist 10:842\u2013848","journal-title":"Oncologist"},{"key":"1012_CR22","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1093\/annonc\/mdl163","volume":"17","author":"G Sanna","year":"2006","unstructured":"Sanna G, Preda L, Bruschini R, CossuRocca M, Ferretti S, Adamoli L, Verri E, Franceschelli L, Goldhirsch A, Nol\u00e8 F (2006) Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer. Ann Oncol 17:1512\u20131516","journal-title":"Ann Oncol"},{"key":"1012_CR23","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/annonc\/mdl408","volume":"18","author":"D AguiarBujanda","year":"2007","unstructured":"AguiarBujanda D, Bohn Sarmiento U, Cabrera Suarez MA, Aguiar Morales J (2007) Assessment of renal toxicity and osteonecrosis of the jaws in patients receiving zoledronic acid for bone metastasis. Ann Oncol 18:556\u2013560","journal-title":"Ann Oncol"},{"key":"1012_CR24","unstructured":"Gr\u00f6tz KA, Piesold J, Al-Nawas B(2012)Bisphosphonat-assoziierteKiefernekrose (BP-ONJ) und andereMedikamenten-assoziierteKiefernekrosen. S3 Leitlinie der DGMKG. AWMF online. http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/007-091l_S3_Bisphosphonat-assoziierte_Kiefernekrose_2012-04.pdf . Accessed: 22 June 2012"},{"issue":"11","key":"1012_CR25","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.amjmed.2010.04.033","volume":"123","author":"S Fedele","year":"2010","unstructured":"Fedele S, Porter SR, D'Aiuto F, Aljohani S, Vescovi P, Manfredi M, Arduino PG, Broccoletti R, Musciotto A, Di Fede O, Lazarovici TS, Campisi G, Yarom N (2010) Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series. Am J Med 123(11):1060\u20131064, Epub 2010 Sep 28","journal-title":"Am J Med"},{"issue":"1","key":"1012_CR26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/annonc\/mdn554","volume":"20","author":"MA Dimopoulos","year":"2009","unstructured":"Dimopoulos MA, Kastritis E, Bamia C, Melakopoulos I, Gika D, Roussou M, Migkou M, Eleftherakis-Papaiakovou E, Christoulas D, Terpos E, Bamias A (2009) Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann Oncol Off J Eur Soc Med Oncol\/ESMO 20(1):117\u2013120","journal-title":"Ann Oncol Off J Eur Soc Med Oncol\/ESMO"},{"issue":"1","key":"1012_CR27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/annonc\/mdn526","volume":"20","author":"CI Ripamonti","year":"2009","unstructured":"Ripamonti CI, Maniezzo M, Campa T, Fagnoni E, Brunelli C, Saibene G, Bareggi C, Ascani L, Cislaghi E (2009) Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The Experience of the National Cancer Institute of Milan. Ann Oncol Off J Eur Soc Med Oncol\/ESMO 20(1):137\u2013145","journal-title":"Ann Oncol Off J Eur Soc Med Oncol\/ESMO"},{"issue":"5","key":"1012_CR28","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.tripleo.2009.12.005","volume":"109","author":"NS Treister","year":"2010","unstructured":"Treister NS, Friedland B, Woo SB (2010) Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109(5):753\u2013764, Epub 2010 Mar 29","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod."},{"issue":"6","key":"1012_CR29","first-page":"e21","volume":"110","author":"D Cohen","year":"2010","unstructured":"Cohen D, Bhattacharyya I, Dashti H, Kuklani R, Fitzpatrick S, Islam MN, Magliocca K (2010) Radiographic features of oral bisphosphonate-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110(6):e21\u2013e22","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"1012_CR30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00784-009-0311-3","volume":"14","author":"S Elad","year":"2010","unstructured":"Elad S, Gomori MJ, Ben-Ami N, Friedlander-Barenboim S, Regev E, Lazarovici TS, Yarom N (2010) Bisphosphonate-related osteonecrosis of the jaw: clinical correlations with computerized tomography presentation. Clin Oral Investig 14(1):43\u201350","journal-title":"Clin Oral Investig"},{"key":"1012_CR31","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.oraloncology.2008.10.001","volume":"45","author":"SB Woo","year":"2009","unstructured":"Woo SB, Mawardi H, Treister N (2009) Letter to the Editor. Comments on \u201cOsteonecrosis of the jaws in intravenous bisphosphonate use: proposal for a modification of the clinical classification\u201d. Oral Oncol 45:740","journal-title":"Oral Oncol"},{"key":"1012_CR32","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.oraloncology.2008.05.011","volume":"45","author":"JV Bagan","year":"2009","unstructured":"Bagan JV, Jimenez Y, Diaz JM, Murillo J, Sanchis JM, Poveda R, Carbonell E, Gavalda C, Scully C (2009) Letter to the Editor. Osteonecrosis of the jaws in intravenous bisphosphonate use: proposal for a modification of the clinical classification. Oral Oncol 45:645\u2013646","journal-title":"Oral Oncol"},{"issue":"3","key":"1012_CR33","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.joms.2008.09.031","volume":"67","author":"H Mawardi","year":"2009","unstructured":"Mawardi H, Treister N, Richardson P, Anderson K, Munshi N, Faiella RA, Woo SB (2009) Sinus tracts\u2014an early sign of bisphosphonate-associated osteonecrosis of the jaws? J Oral Maxillofac Surg 67(3):593\u2013601","journal-title":"J Oral Maxillofac Surg."},{"issue":"2","key":"1012_CR34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tripleo.2011.02.037","volume":"112","author":"O Nicolatou-Galitis","year":"2011","unstructured":"Nicolatou-Galitis O, Papadopoulou E, Sarri T, Boziari P, Karayianni A, Kyrtsonis MC, Repousis P, Barbounis V, Migliorati CA (2011) Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112(2):195\u2013202, Epub 2011 May 31","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod."},{"issue":"2","key":"1012_CR35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/annonc\/mdn630","volume":"20","author":"T Wyngaert Van den","year":"2009","unstructured":"Van den Wyngaert T, Claeys T, Huizing MT, Vermorken JB, Fossion E (2009) Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome. Ann Oncol 20(2):331\u2013336, Epub 2008 Oct 26","journal-title":"Ann Oncol"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-013-1012-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00784-013-1012-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-013-1012-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,14]],"date-time":"2019-07-14T20:53:23Z","timestamp":1563137603000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00784-013-1012-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,10]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["1012"],"URL":"https:\/\/doi.org\/10.1007\/s00784-013-1012-5","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,10]]}}}